Table 3.
Multivariate analysis of metastatic PCa.
| Variate | No. | Progression-free survival |
Overall survival |
||||
|---|---|---|---|---|---|---|---|
| HRa | 95% CIa | p value | HRa | 95% CIa | p value | ||
| Visceral fat percentage (per 1%) | 0.990 | 0.973-1.006 | 0.238 | 0.992 | 0.221-2.258 | 0.544 | |
| V/S ratio (per 1) | 1.004 | 0.980-0.029 | 0.714 | 1.003 | 0.958-1.049 | 0.899 | |
| Psoas muscle ratio (per 1 cm3/cm) | 1.035 | 0.642-1.630 | 0.882 | 0.448 | 0.206-0.922 | 0.028 | |
| BMI (per 1 kg/m2) | 0.972 | 0.904-1.043 | 0.441 | 0.915 | 0.823-1.013 | 0.091 | |
Abbreviations: BMI, body mass index; HR, hazard ratio; CI, confidence interval; PSA, prostate-specific antigen.
Adjusted for age, GS, PSA at diagnosis, cT stage and cM stage.